Obalon Therapeutics, Inc. (OBLN) |
| 3.05 -0.19 (-5.86%) 06-16 00:00 |
| Open: | 3.25 |
| High: | 4.8 |
| Low: | 2.948 |
| Volume: | 26,469,075 |
| Market Cap: | 5(M) |
| PE Ratio: | -2.22 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 29.05 |
| Resistance 1: | 27.74 |
| Pivot price: | 26.74 |
| Support 1: | 25.60 |
| Support 2: | 21.30 |
| 52w High: | 32.31003 |
| 52w Low: | 1.980001 |
Financials
| EPS | -1.620 |
| Book Value | 16.190 |
| PEG Ratio | 7.05 |
| Gross Profit | 3.754 |
| Profit Margin (%) | -2.75 |
| Operating Margin (%) | -4.15 |
| Return on Assets (ttm) | 0.1 |
| Return on Equity (ttm) | -9.8 |
Company news
Tue, 19 Aug 2025
Synchron Expands Executive Team with Appointment of Andy Rasdal as Chief of Staff and Mark Brister as VP R&D - Business Wire
Thu, 07 Aug 2025
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire
Mon, 13 Jan 2025
ReShape Lifesciences® Provides Update on Merger Agreement - GlobeNewswire
Fri, 01 Dec 2023
ReShape and Obalon Merge in All-Stock Transaction - Medical Device and Diagnostic industry
Sat, 29 Jul 2023
Jonah Shacknai Net Worth (2026) - GuruFocus
Fri, 18 Dec 2020
OBLN Stock: 11 Things to Know About Weight Loss Balloon Play Obalon Therapeutics - InvestorPlace
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
